Patience required from investors as big US deals take time to deliver.
Tim Hunter Fri, 01 Dec 2017
If Pacific Edge shareholders were hopeful good times were just around the corner they got a reality check from the trickle of cash income in its half-year results.
After allowing for income from a Callaghan Growth Grant, the bladder cancer diagnostics company pulled in just $1.3 million from
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).